Opendata, web and dolomites

IMPACT SIGNED

Improving DNA Analysis for Correct Healthcare

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 IMPACT project word cloud

Explore the words cloud of the IMPACT project. It provides you a very rough idea of what is the project "IMPACT" about.

operate    plan    molecule    encompasses    providers    revolutionized    samplix    medical    revenue    biological    droplet    xdrop    sequencing    cancer    preparation    personalized    full    scientists    proprietary    biopsies    2018    barriers    despite    trade    round    musd    minute    genetics    single    agreements    razor    overcome    qualify    oem    droplets    immunological    shortcomings    selling    launch    patent    diseases    amount    bioinformatics    disorders    reaction    brings    material    aggregated    total    subscription    core    bigger    site    molecular    raised    capital    profitability    free    chamber    opposed    generation    retrieve    microfluidics    engaged    molecules    complexity    subsequent    consumables    place    healthcare    diagnosis    mental    biology    estate    market    strategy    strive    constituting    team    bulk    millions    gt    blade    sales    instrument    multibillion    tumour    freedom    2019    resolution    put    globe    drug    return    families    installing    commercial    dna    over    financing   

Project "IMPACT" data sheet

The following table provides information about the project.

Coordinator
SAMPLIX ApS 

Organization address
address: MILEPARKEN 28
city: HERLEV
postcode: 2730
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 2˙669˙623 €
 EC max contribution 1˙868˙736 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2021-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SAMPLIX ApS DK (HERLEV) coordinator 1˙868˙736.00

Map

 Project objective

Over the past 10 years DNA sequencing has revolutionized how we apply genetics in personalized healthcare, diagnosis and drug development despite that the sequencing technology comes with numerous shortcomings. Samplix has developed a proprietary technology, Xdrop™, which addresses these shortcomings. Samplix’ technology encompasses state of the art microfluidics, molecular biology and bioinformatics. The Xdrop technology enables scientists and medical personnel to retrieve specific single DNA molecules from a minute amount of biological sample e.g. tumour biopsies, for subsequent DNA sequencing. At the core of the Xdrop technology is the generation of millions of droplets, each droplet constituting a reaction chamber for the sample preparation of single DNA molecules. This is opposed to today’s technology which is based on bulk preparation of sample material for DNA sequencing. Single molecule resolution is key to understanding the complexity of major diseases such as cancer, immunological diseases, mental disorders, etc. The proposed project addresses the need to qualify known market barriers and put measures in place to overcome such market barriers. Samplix has engaged a very experienced management team with an aggregated experience of >50 years in developing and selling products for DNA analysis. Samplix has already established: • 5 test site agreements with leading DNA institutions around the globe • Agreements with leading OEM providers on instrument and consumables • A patent estate of 5 patent families. • Freedom to operate in multibillion € market. At Samplix, we strive at 100 mUSD in revenue and profitability in year five after full commercial launch. To achieve such an ambitious goal, we plan to apply a razor/razor blade sales strategy by installing the instrument “for free” in return for a subscription to consumables Samplix raised 4,5 m€ in May 2018 which brings the total capital raised to 8 m€. A bigger financing round is planned for 2019.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IMPACT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IMPACT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

HAC (2019)

ADVANCED TREATMENT OF CONTAMINATED SOIL

Read More  

COPI (2020)

Carbon Offset Plug-in

Read More